The FASEB Journal, Vol 6, 711-718, Copyright © 1992 by The Federation of American Societies for Experimental Biology

REVIEWS

Hepatic steroid hydroxylating enzymes are controlled by the sexually dimorphic pattern of growth hormone secretion in normal and dwarf rats

C Legraverend, A Mode, T Wells, I Robinson and JA Gustafsson
Department of Medical Nutrition, Karolinska Institute, Huddinge University Hospital, Sweden.

In rats, the onset of the sexually dimorphic pattern of growth hormone (GH) secretion and increased hepatic GH-binding capacity at puberty are temporally correlated with the sex-dependent expression of some hepatic cytochrome P450 enzymes involved in steroid metabolism. There are indications that the expression of the GH receptor gene itself is dependent on the sexually differentiated pattern of GH secretion. However, the molecular mechanisms by which a given pattern of GH secretion turns on a specific set of genes in the hepatocyte are not yet understood. Studies of the cytochrome P450 2C gene subfamily in hypophysectomized rats and isolated hepatocytes suggest that one major mechanism of GH action in the liver occurs through modulation of gene transcriptional initiation. The occurrence, in dwarf rats and in rats treated neonatally with monosodium glutamate, of sex differences in GH secretion and liver steroid metabolism typical of normal rats, in spite of a 95% reduction in pituitary GH levels, is compatible with the notion that extremely low levels of circulating GH are sufficient to regulate the expression of liver steroid-metabolizing enzymes. This, together with the fact that single daily subcutaneous injections of GH are sufficient to masculinize the liver of a hypophysectomized rat, indicates that neither the amplitude nor the frequency of the GH pulse is recognized as male or female by the hepatocyte, but rather the complete and prolonged suppression (in males) or the persistence (in females) of circulating GH during the trough period after a GH surge.

This article has been cited by other articles:

				J. S. Davies, E. F. Gevers, A. E. Stevenson, K. T. Coschigano, M. M. El-Kasti, M. J. Bull, C. Elford, B. A. J. Evans, J. J. Kopchick, and T. Wells Adiposity profile in the dwarf rat: an unusually lean model of profound growth hormone deficiency Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1483 - E1494. [Abstract] [Full Text] [PDF]

				X. Cheng, J. Maher, H. Lu, and C. D. Klaassen Endocrine Regulation of Gender-Divergent Mouse Organic Anion-Transporting Polypeptide (Oatp) Expression Mol. Pharmacol., October 1, 2006; 70(4): 1291 - 1297. [Abstract] [Full Text] [PDF]

				X. Yang, E. E. Schadt, S. Wang, H. Wang, A. P. Arnold, L. Ingram-Drake, T. A. Drake, and A. J. Lusis Tissue-specific expression and regulation of sexually dimorphic genes in mice Genome Res., August 1, 2006; 16(8): 995 - 1004. [Abstract] [Full Text] [PDF]

				R. N. Dhir, W. Dworakowski, C. Thangavel, and B. H. Shapiro Sexually Dimorphic Regulation of Hepatic Isoforms of Human Cytochrome P450 by Growth Hormone J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 87 - 94. [Abstract] [Full Text] [PDF]

				I. Huerta-Ocampo, H. C. Christian, N. M. Thompson, M. M. El-Kasti, and T. Wells The Intermediate Lactotroph: A Morphologically Distinct, Ghrelin-Responsive Pituitary Cell in the Dwarf (dw/dw) Rat Endocrinology, November 1, 2005; 146(11): 5012 - 5023. [Abstract] [Full Text] [PDF]

				A. S. Verma, R. N. Dhir, and B. H. Shapiro Inadequacy of the Janus Kinase 2/Signal Transducer and Activator of Transcription Signal Transduction Pathway to Mediate Episodic Growth Hormone-Dependent Regulation of Hepatic CYP2C11 Mol. Pharmacol., March 1, 2005; 67(3): 891 - 901. [Abstract] [Full Text] [PDF]

				C. A. Wiwi and D. J. Waxman Role of Hepatocyte Nuclear Factors in Transcriptional Regulation of Male-specific CYP2A2 J. Biol. Chem., February 4, 2005; 280(5): 3259 - 3268. [Abstract] [Full Text] [PDF]

				D. S. Riddick, C. Lee, A. Bhathena, Y. E. Timsit, P.-Y. Cheng, E. T. Morgan, R. A. Prough, S. L. Ripp, K. K. M. Miller, A. Jahan, et al. TRANSCRIPTIONAL SUPPRESSION OF CYTOCHROME P450 GENES BY ENDOGENOUS AND EXOGENOUS CHEMICALS Drug Metab. Dispos., April 1, 2004; 32(4): 367 - 375. [Abstract] [Full Text] [PDF]

				R. N. Dhir and B. H. Shapiro Interpulse growth hormone secretion in the episodic plasma profile causes the sex reversal of cytochrome P450s in senescent male rats PNAS, December 9, 2003; 100(25): 15224 - 15228. [Abstract] [Full Text] [PDF]

				F. Gueraud, D. Daveloose, H. Vezin, J. Viret, and A. Paris In Vivo Modification of the UDP-Glucuronosyltransferase Functional State in Rat Liver Following Hypophysectomy and Partial or Complete Hormonal Restoration J. Biochem., November 1, 2003; 134(5): 641 - 653. [Abstract] [Full Text] [PDF]

				N. M. Thompson, J. S Davies, A. Mode, P. A. Houston, and T. Wells Pattern-Dependent Suppression of Growth Hormone (GH) Pulsatility by Ghrelin and GH-Releasing Peptide-6 in Moderately GH-Deficient Rats Endocrinology, November 1, 2003; 144(11): 4859 - 4867. [Abstract] [Full Text] [PDF]

				S. K. Jessup, E. V. Dimaraki, K. V. Symons, and A. L. Barkan Sexual Dimorphism of Growth Hormone (GH) Regulation in Humans: Endogenous GH-Releasing Hormone Maintains Basal GH in Women But Not in Men J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4776 - 4780. [Abstract] [Full Text] [PDF]

				M. Jalouli, L. Carlsson, C. Ameen, D. Linden, A. Ljungberg, L. Michalik, S. Eden, W. Wahli, and J. Oscarsson Sex Difference in Hepatic Peroxisome Proliferator-Activated Receptor {alpha} Expression: Influence of Pituitary and Gonadal Hormones Endocrinology, January 1, 2003; 144(1): 101 - 109. [Abstract] [Full Text] [PDF]

				F. R. Simon, J. Fortune, M. Iwahashi, and E. Sutherland Sexual dimorphic expression of ADH in rat liver: importance of the hypothalamic-pituitary-liver axis Am J Physiol Gastrointest Liver Physiol, September 1, 2002; 283(3): G646 - G655. [Abstract] [Full Text] [PDF]

				A. Kaufhold, P. K. Nigam, R. N. Dhir, and B. H. Shapiro Prevention of Latently Expressed CYP2C11, CYP3A2, and Growth Hormone Defects in Neonatally Monosodium Glutamate-Treated Male Rats by the N-Methyl-D-Aspartate Receptor Antagonist Dizocilpine Maleate J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 490 - 496. [Abstract] [Full Text] [PDF]

				R. N. Dhir, W. Dworakowski, and B. H. Shapiro Middle-Age Alterations in the Sexually Dimorphic Plasma Growth Hormone Profiles: Involvement of Growth Hormone-Releasing Factor and Effects on Cytochrome P450 Expression Drug Metab. Dispos., February 1, 2002; 30(2): 141 - 147. [Abstract] [Full Text] [PDF]

				A. V. Kuperman, A. S. Kalgutkar, A. Marfat, R. J. Chambers, and T. E. Liston Pharmacokinetics and Metabolism of a Cysteinyl Leukotriene-1 Receptor Antagonist from the Heterocyclic Chromanol Series in Rats: In Vitro-In Vivo Correlation, Gender-Related Differences, Isoform Identification, and Comparison with Metabolism in Human Hepatic Tissue Drug Metab. Dispos., November 1, 2001; 29(11): 1403 - 1409. [Abstract] [Full Text] [PDF]

				M. C. Garcia, C. Thangavel, and B. H. Shapiro Epidermal Growth Factor Regulation of Female-Dependent CYP2A1 and CYP2C12 in Primary Rat Hepatocyte Culture Drug Metab. Dispos., February 1, 2001; 29(2): 111 - 120. [Abstract] [Full Text]

				N. A. Pampori, A. K. Agrawal, and B. H. Shapiro Infusion of Gender-Dependent Plasma Growth Hormone Profiles Into Intact Rats: Effects of Subcutaneous, Intraperitoneal, and Intravenous Routes of Rat and Human Growth Hormone on Endogenous Circulating Growth Hormone Profiles and Expression of Sexually Dimorphic Hepatic Cyp Isoforms Drug Metab. Dispos., January 1, 2001; 29(1): 8 - 16. [Abstract] [Full Text]

				N. A. Pampori and B. H. Shapiro Nominal Growth Hormone Pulses in Otherwise Normal Masculine Plasma Profiles Induce Intron Retention of Overexpressed Hepatic CYP2C11 with Associated Nuclear Splicing Deficiency Endocrinology, November 1, 2000; 141(11): 4100 - 4106. [Abstract] [Full Text] [PDF]

				A. K. Agrawal and B. H. Shapiro Differential Expression of Gender-Dependent Hepatic Isoforms of Cytochrome P-450 by Pulse Signals in the Circulating Masculine Episodic Growth Hormone Profile of the Rat J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 228 - 237. [Abstract] [Full Text]

				P. Tollet-Egnell, A. Flores-Morales, A. Stavréus-Evers, L. Sahlin, and G. Norstedt Growth Hormone Regulation of SOCS-2, SOCS-3, and CIS Messenger Ribonucleic Acid Expression in the Rat Endocrinology, August 1, 1999; 140(8): 3693 - 3704. [Abstract] [Full Text]

				N. A. Pampori and B. H. Shapiro Gender Differences in the Responsiveness of the Sex-Dependent Isoforms of Hepatic P450 to the Feminine Plasma Growth Hormone Profile Endocrinology, March 1, 1999; 140(3): 1245 - 1254. [Abstract] [Full Text]

				K. A. Robinson, S. M. Willi, S. Bingel, and M. G. Buse Decreased hexosamine biosynthesis in GH-deficient dwarf rat muscle. Reversal with GH, but not IGF-I, therapy Am J Physiol Endocrinol Metab, March 1, 1999; 276(3): E435 - E442. [Abstract] [Full Text] [PDF]

				M. D. Anderson, S. M. Bandiera, T. K. H. Chang, and G. D. Bellward Effect of Androgen Administration During Puberty on Hepatic CYP2C11, CYP3A, and CYP2A1 Expression in Adult Female Rats Drug Metab. Dispos., October 1, 1998; 26(10): 1031 - 1038. [Abstract] [Full Text]

				C. Buggs, N. Nasrin, A. Mode, P. Tollet, H.-F. Zhao, J.-A. Gustafsson, and M. Alexander-Bridges IRE-ABP (Insulin Response Element-A Binding Protein), an SRY-Like Protein, Inhibits C/EBP{alpha} (CCAAT/Enhancer-Binding Protein {alpha})-Stimulated Expression of the Sex-Specific Cytochrome P450 2C12 Gene Mol. Endocrinol., September 1, 1998; 12(9): 1294 - 1309. [Abstract] [Full Text]

				J. C. Corton, L.-Q. Fan, S. Brown, S. P. Anderson, C. Bocos, R. C. Cattley, A. Mode, and J.-A. Gustafsson Down-Regulation of Cytochrome P450 2C Family Members and Positive Acute-Phase Response Gene Expression by Peroxisome Proliferator Chemicals Mol. Pharmacol., September 1, 1998; 54(3): 463 - 473. [Abstract] [Full Text]

				J. H. Lin and A. Y. H. Lu Role of Pharmacokinetics and Metabolism in Drug Discovery and Development Pharmacol. Rev., December 1, 1997; 49(4): 403 - 449. [Abstract] [Full Text] [PDF]

				P. C. Hindmarsh, C. H. D. Fall, P. J. Pringle, C. Osmond, and C. G. D. Brook Peak and Trough Growth Hormone Concentrations Have Different Associations with the Insulin-Like Growth Factor Axis, Body Composition, and Metabolic Parameters J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2172 - 2176. [Abstract] [Full Text] [PDF]

				S. A. Nelson and D. M. Robins Two Distinct Mechanisms Elicit Androgen-Dependent Expression of the Mouse Sex-Limited Protein Gene Mol. Endocrinol., April 1, 1997; 11(4): 460 - 469. [Abstract] [Full Text]

				T. Wells, D. M. Flavell, S. E. Wells, D. F. Carmignac, and I. C. A. F. Robinson Effects of Growth Hormone Secretagogues in the Transgenic Growth-Retarded (Tgr) Rat Endocrinology, February 1, 1997; 138(2): 580 - 587. [Abstract] [Full Text] [PDF]

				A. Yamada, M. Yamada, Y. Fujita, T. Nishigami, K. Nakasho, and K. Uematsu Self-augmentation Effect of Male-specific Products on Sexually Differentiated Progesterone Metabolism in Adult Male Rat Liver Microsomes J. Biol. Chem., February 9, 2001; 276(7): 4604 - 4610. [Abstract] [Full Text] [PDF]